Company Profile
Zhejiang Sunflower Great Health researches, develops, produces, and sells anti-infectious, cardiovascular, digestive system and other drugs in China and globally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pneumonia, and urethritis and cervicitis
Azithromycin dispersible tablets and injections for sinusitis, acute otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, streptococcus pneumoniae, pneumonia, haemophilus influenzae, mycoplasma pneumoniae, urethritis, cervicitis and skin and soft tissue infection Roxithromycin capsules to treat pharyngitis and tonsillitis caused by Streptococcus pyogenes, sinusitis, otitis media, acute bronchitis, acute exacerbation
Urethritis, cervicitis, and skin and soft tissue infection. Additionally, it offers lacidipine dispersible tablets for the treatment of high blood pressure; and simvastatin tablets used for hyperlipidemia, coronary heart disease combined with hypercholesterolemia, and children with heterozygous familial hypercholesterolemia
Omeprazole sodium for injection, a digestive system drug, used as an alternative therapy for duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome Famotidine for injection for treatment of peptic ulcer bleeding, acute gastric mucosal damage, and gastrointestinal bleeding caused by non-steroidal anti-inflammatory drugs.
Founded in 2005 and headquartered in Shaoxing, China, Zhejiang Sunflower Great Health was formerly known as Zhejiang Sunflower Great Health Limited Liability Company before rebranding in December 2023.